![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | |
C07K 16/28 | |||
A61P 35/00 |
(11) | Number of the document | 3169361 |
(13) | Kind of document | T |
(96) | European patent application number | 15747647.4 |
Date of filing the European patent application | 2015-07-15 | |
(97) | Date of publication of the European application | 2017-05-24 |
(45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/040582 |
Date | 2015-07-15 |
(87) | Number | WO 2016/011160 |
Date | 2016-01-21 |
(30) | Number | Date | Country code |
201462024988 P | 2014-07-15 | US |
(72) |
JUNTTILA, Melissa, US
|
(73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(54) | COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS |
COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS |